3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
58
Recurrence
7
Neoplasms, Plasma Cell
6
Lymphoma
6
Immunoglobulin Light-chain Amyloidosis
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Paraproteinemias
2
Neoplasms
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Leukemia, Myeloid, Acute
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Thalassemia
1
Sarcoma, Myeloid
1
Renal Insufficiency
1
Prostatic Neoplasms
1
Plasmablastic Lymphoma
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Interventions
Radiotherapy, Conformal
2
Radiotherapy
2
Paclitaxel
2
Nivolumab
2
Carboplatin
2
veliparib
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
Taxes
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Platinum
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunoglobulin G
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Docetaxel
1
Disulfides
1
Cisplatin
1
CTLA-4 Antigen
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma, Bronchiolo-Alveolar
×
Bortezomib
×
90 days
×
Clear all
No trials found.